$SCYX
SCYNEXIS INC Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000117825314000020 Filed on November 13, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$1.060M	$61.00K	$4.163M
YoY Change	-71.12%	-98.53%
Cost Of Revenue		$3.660M	$3.986M
YoY Change		-8.18%
Gross Profit		$720.0K	$177.0K
YoY Change		306.78%
Gross Profit Margin		1180.33%	4.25%
Selling, General & Admin	$2.030M	$2.121M	$1.141M
YoY Change	65.04%	85.89%
% of Gross Profit		294.58%	644.63%
Research & Development	$2.670M	$2.478M	$1.050M
YoY Change	130.17%	136.0%
% of Gross Profit		344.17%	593.22%
Depreciation & Amortization	$320.0K	$303.0K	$321.0K
YoY Change		-5.61%
% of Gross Profit		42.08%	181.36%
Operating Expenses	$4.700M	$4.599M	$2.189M
YoY Change	95.83%	110.1%
Operating Profit		-$4.538M	-$2.012M
YoY Change		125.55%
Interest Expense	$0.00	$0.00	-$46.00K
YoY Change	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	-$1.948M
YoY Change		-100.0%
Pretax Income	-$3.640M	-$4.538M	-$3.960M
YoY Change	-83.25%	14.6%
Income Tax	-$260.0K	-$338.0K	$0.00
% Of Pretax Income
Net Earnings	-$3.080M	-$3.804M	-$3.960M
YoY Change	-85.83%	-3.94%
Net Earnings / Revenue	-290.57%	-6236.07%	-95.12%
Basic Earnings Per Share		-$0.45	-$11.79
Diluted Earnings Per Share	-$3.624M	-$0.45	-$11.79
COMMON SHARES
Basic Shares Outstanding	8.512M shares	8.505M shares	335.9K shares
Diluted Shares Outstanding		8.505M shares	335.9K shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.20M	$34.00M
YoY Change
Cash & Equivalents	$32.24M	$34.04M	$926.0K
Short-Term Investments
Other Short-Term Assets	$3.000K	$1.800M
YoY Change	-40.0%
Inventory
Prepaid Expenses
Receivables	$1.118M	$999.0K
Other Receivables		$0.00
Total Short-Term Assets	$39.65M	$36.80M
YoY Change	369.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$5.060M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$25.00K	$106.0K
YoY Change	0.0%
Total Long-Term Assets	$25.00K	$5.166M
YoY Change	-99.37%
TOTAL ASSETS
Total Short-Term Assets	$39.65M	$36.80M
Total Long-Term Assets	$25.00K	$5.166M
Total Assets	$39.67M	$41.96M
YoY Change	220.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$426.0K	$640.0K
YoY Change	-71.99%
Accrued Expenses	$2.245M	$2.021M
YoY Change	206.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change	-100.0%
Total Short-Term Liabilities	$5.348M	$3.197M
YoY Change	-73.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$900.0K	$2.600M
YoY Change
Total Long-Term Liabilities	$900.0K	$2.600M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.348M	$3.197M
Total Long-Term Liabilities	$900.0K	$2.600M
Total Liabilities	$6.241M	$5.822M
YoY Change	-81.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$117.5M	-$114.4M
YoY Change	3.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.43M	$36.14M
YoY Change
Total Liabilities & Shareholders Equity	$39.67M	$41.96M
YoY Change	220.27%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$3.080M	-$3.804M	-$3.960M
YoY Change	-85.83%	-3.94%
Depreciation, Depletion And Amortization	$320.0K	$303.0K	$321.0K
YoY Change		-5.61%
Cash From Operating Activities	-$1.720M	-$3.680M	-$150.0K
YoY Change		2353.33%
INVESTING ACTIVITIES
Capital Expenditures	-$70.00K	-$310.0K	-$60.00K
YoY Change		416.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$70.00K	-$310.0K	-$50.00K
YoY Change		520.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-400.0K	260.0K
YoY Change		-253.85%
NET CHANGE
Cash From Operating Activities	-1.720M	-3.680M	-150.0K
Cash From Investing Activities	-70.00K	-310.0K	-50.00K
Cash From Financing Activities	0.000	-400.0K	260.0K
Net Change In Cash	-1.790M	-4.390M	60.00K
YoY Change		-7416.67%
FREE CASH FLOW
Cash From Operating Activities	-$1.720M	-$3.680M	-$150.0K
Capital Expenditures	-$70.00K	-$310.0K	-$60.00K
Free Cash Flow	-$1.650M	-$3.370M	-$90.00K
YoY Change		3644.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1932000	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	640000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	719000	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	999000	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2021000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1058000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17669000	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18447000	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	150570000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5168000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	837000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	109000	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	455000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	163000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	75000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	10000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	755000	USD
CY2014Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2504000	USD
CY2013Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	982000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	51000	USD
CY2013Q4	us-gaap	Assets Assets	12387000	USD
CY2014Q3	us-gaap	Assets Assets	41964000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2953000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	36798000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1402000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34036000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	926000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1459000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	32634000	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.20
CY2014Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	13879	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2134277	shares
CY2014Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	847711	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8512103	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334068	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8512103	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334068	shares
CY2014Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	88788000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2014Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1691884	shares
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	3660000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	3986000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12531000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	11800000	USD
CY2014Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2013Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2144000	USD
CY2014Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2013Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1775000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1481000	USD
CY2014Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1384000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	487000	USD
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	536000	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1241000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1144000	USD
	us-gaap	Depreciation Depreciation	1012000	USD
	us-gaap	Depreciation Depreciation	918000	USD
CY2013Q3	us-gaap	Depreciation Depreciation	321000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	303000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12237000	USD
CY2014Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2014Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2701000	USD
	us-gaap	Dilutive Securities DilutiveSecurities	-10080000	USD
CY2014Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2013Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-11.79
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-25.99
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-11.79
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-25.99
CY2014Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2013Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3290000	USD
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	0	USD
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	-15000000	USD
CY2013Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	671000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	671000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10080000	USD
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	899000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	544000	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2522000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	683000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12237000	USD
CY2013Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1851000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2013Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	988000	USD
CY2014Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1389000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	177000	USD
	us-gaap	Gross Profit GrossProfit	653000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	720000	USD
	us-gaap	Gross Profit GrossProfit	1927000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	180000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	907000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-337000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	147000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1580000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	703000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	876000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	307000	USD
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	273687	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	165000	USD
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	USD
CY2014Q3	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	USD
CY2013Q3	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	USD
CY2013Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	249000	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	703000	USD
CY2014Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49000	USD
CY2013Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-46000	USD
CY2014Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	0	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-142000	USD
	us-gaap	Interest Paid InterestPaid	148000	USD
	us-gaap	Interest Paid InterestPaid	49000	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	237000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	687000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	702000	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	235000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	33339000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	5822000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12387000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41964000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18477000	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3197000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	282000	USD
CY2014Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	93000	USD
CY2013Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	29000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	91000	USD
CY2014Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	15000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	40801000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	902000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-416000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	618000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2979000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7751000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3960000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3804000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8732000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2792000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3804000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12872000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3960000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8732000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7877000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1948000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4020000	USD
	us-gaap	Operating Expenses OperatingExpenses	5365000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	2189000	USD
	us-gaap	Operating Expenses OperatingExpenses	10963000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	4524000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3804000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4712000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9036000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2012000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	5013000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1156000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1123000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1104000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1075000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	291000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	264000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	114000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	106000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	6875000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	370000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	632000	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1373000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	489000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	899000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	216000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2014Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	54583000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	544000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	68000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	USD
CY2014Q1	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	500000	USD
CY2012Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	313000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	988000	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	USD
CY2013Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	55000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-3960000	USD
	us-gaap	Profit Loss ProfitLoss	-1159000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-3804000	USD
	us-gaap	Profit Loss ProfitLoss	-8732000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23070000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23507000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5401000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5060000	USD
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
CY2013Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
CY2014Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	500000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1050000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2478000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3203000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5621000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113277000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114436000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5466000	USD
CY2013Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1822000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5466000	USD
CY2014Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1822000	USD
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-top:8px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company derives the majority of its revenue from providing contract research and development services under fee for service arrangements. The Company also has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:inherit;font-size:10pt;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s contract research and development services revenue is recognized in the period in which the services are performed. The Company historically has recognized milestone payments received on a straight-line basis over the remaining service period. No milestone payments were received in the periods presented in the accompanying statements of operations. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. Therefore, license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company recognized an immaterial amount of license revenue from the receipt of upfront payments in the accompanying statement of operations. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-top:16px;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s deferred revenue comprises upfront payments received and is recognized over the estimated relationship period. The Company received upfront payments of </font><font style="font-family:inherit;font-size:10pt;">$313</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1,500</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$500</font><font style="font-family:inherit;font-size:10pt;"> in August 2012, August 2013 and January 2014, respectively, which are recognized over periods of </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months, </font><font style="font-family:inherit;font-size:10pt;">70</font><font style="font-family:inherit;font-size:10pt;"> months and </font><font style="font-family:inherit;font-size:10pt;">48</font><font style="font-family:inherit;font-size:10pt;"> months, respectively. The Company recognized revenue from these upfront payments of </font><font style="font-family:inherit;font-size:10pt;">$93</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$282</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">for the three and nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">September 30, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$29</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$91</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">for the three and nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">September 30, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>
CY2013Q3	us-gaap	Revenues Revenues	4163000	USD
	us-gaap	Revenues Revenues	13184000	USD
	us-gaap	Revenues Revenues	13727000	USD
CY2014Q3	us-gaap	Revenues Revenues	4380000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	7718000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	2558000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	8261000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	2341000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5507000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3150000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1141000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2046000	USD
CY2014Q2	us-gaap	Severance Costs1 SeveranceCosts1	379000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	49734	shares
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	137610	shares
CY2014Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	625627	shares
CY2014Q2	us-gaap	Share Price SharePrice	10.00
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1691884	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	10048	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	416	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-108109000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	36142000	USD
CY2014Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.196
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4 reverse stock split
CY2013Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
CY2014Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	-510000	USD
CY2014Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	29135824	shares
CY2013Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	343000	USD
CY2014Q3	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	390000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8504785	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	335930	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	335938	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4976965	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335930	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8504785	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335938	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4703278	shares
CY2014Q3	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2014Q3	scyx	Common Stock Capital Shares Reserved For Future Issuance For Conversion Of Preferred Stock And Exercise Of Warrants CommonStockCapitalSharesReservedForFutureIssuanceForConversionOfPreferredStockAndExerciseOfWarrants	0	shares
CY2013Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance For Conversion Of Preferred Stock And Exercise Of Warrants CommonStockCapitalSharesReservedForFutureIssuanceForConversionOfPreferredStockAndExerciseOfWarrants	1675812	shares
CY2013Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants	257242	shares
CY2014Q3	scyx	Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants	0	shares
	scyx	Deemed Contribution Of Loan Guarantee DeemedContributionOfLoanGuarantee	3930000	USD
	scyx	Deemed Contribution Of Loan Guarantee DeemedContributionOfLoanGuarantee	0	USD
	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	909000	USD
CY2013Q3	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2014Q1	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P48M
	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2014Q3	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2013Q3	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
CY2014Q3	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	214000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	4127000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	0	USD
	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2012Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P6M
	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	-10442000	USD
CY2013Q3	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	671000	USD
	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	671000	USD
	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	362000	USD
	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	269000	USD
CY2013Q3	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	0	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-38000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-97000	USD
CY2014Q1	scyx	Ipo Gross Proceeds Threshold That Triggers Automatic Conversion Of Preferred Stock IpoGrossProceedsThresholdThatTriggersAutomaticConversionOfPreferredStock	20000000	USD
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
	scyx	Lease Expiration Extension Date Under Option LeaseExpirationExtensionDateUnderOption	2024-03-31
	scyx	Lease Expiration Year LeaseExpirationYear	2019
	scyx	Milestone Payments MilestonePayments	19000000	USD
CY2014Q3	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2014Q2	scyx	Offering Expenses OfferingExpenses	4127000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	11000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	0	USD
CY2014Q3	scyx	Remaining Unpaid Accrued Severance Balance RemainingUnpaidAccruedSeveranceBalance	163000	USD
	scyx	Required Percentage Written Consent By Holders Of Outstanding Aggregated Principle Amount Of Convertible Notes RequiredPercentageWrittenConsentByHoldersOfOutstandingAggregatedPrincipleAmountOfConvertibleNotes	0.70
	scyx	Severance Disbursements SeveranceDisbursements	216000	USD
CY2014Q2	scyx	Temporary Equity Shares Issued And Outstanding TemporaryEquitySharesIssuedAndOutstanding	17803273	shares
	scyx	Warrant Derivative Liability Reclassified To Additional Paid In Capital WarrantDerivativeLiabilityReclassifiedToAdditionalPaidInCapital	0	USD
	scyx	Warrant Derivative Liability Reclassified To Additional Paid In Capital WarrantDerivativeLiabilityReclassifiedToAdditionalPaidInCapital	2701000	USD
CY2013Q3	scyx	Warrant Derivative Liability Reclassified To Additional Paid In Capital WarrantDerivativeLiabilityReclassifiedToAdditionalPaidInCapital	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8512103	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-11-04
	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC

Files In Submission

Name	View Source	Status
0001178253-14-000020-index-headers.html	Edgar Link	pending
0001178253-14-000020-index.html	Edgar Link	pending
0001178253-14-000020.txt	Edgar Link	pending
0001178253-14-000020-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
q32014exhibit311.htm	Edgar Link	pending
q32014exhibit312.htm	Edgar Link	pending
q32014exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20140930.xml	Edgar Link	completed
scyx-20140930.xsd	Edgar Link	pending
scyx-20140930x10q.htm	Edgar Link	pending
scyx-20140930_cal.xml	Edgar Link	unprocessable
scyx-20140930_def.xml	Edgar Link	unprocessable
scyx-20140930_lab.xml	Edgar Link	unprocessable
scyx-20140930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS INC Stock $scyx

2014 Q4 Form 10-Q Financial Statement

#000117825314000020 Filed on November 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS INC Stock $scyx

2014 Q4 Form 10-Q Financial Statement

#000117825314000020 Filed on November 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS INC Stock $scyx